Lupin announced that it has entered into a non-exclusive patent license agreement with Takeda Pharmaceutical Company (Takeda), to commercialize Vonoprazan Tablets in the Indian market.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
